Efficacy and safety of intravenous Ig and alterations in haematological parameters of infants with isoimmune haemolytic disease

Arch Dis Child Fetal Neonatal Ed. 2012 Jan;97(1):F76-7. doi: 10.1136/archdischild-2011-300446.
No abstract available

Publication types

  • Letter

MeSH terms

  • Erythroblastosis, Fetal / therapy*
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Infant, Newborn
  • Rh Isoimmunization / therapy*
  • Treatment Outcome

Substances

  • Immunoglobulins, Intravenous